The Company successfully booked total assets of Rp 4.61 trillion, an increase of 34.29% from 2015 of Rp 3.43 trillion. The significant asset growth is a reflection of the increase in current assets owned by the Company

Jakarta (20/04). PT Kimia Farma (Persero) Tbk , which recorded revenues 19.57% increase from 4.86 trillion in 2015 into 5.81 trillion in 2016, in line with the Company's Net Profit also increased by 2,28% from Rp 271.59 billion, at the 2016 Annual General Meeting of Shareholders in Jakarta (20/04) decided to distribute dividends to shareholders at 20% of the profit attributable to the Company in 2016 or Rp 53.48 billion.

In addition to this year's 2016 General Meeting of Shareholders, it was decided to amend the Company's Board of Directors:


Dismiss with respect:
1. Drs. Rusdi Rosman, MBA., Apt. (President Director)
2. Farida Astuti, MBA., Ak. (Director of Finance)
3. Drs. Pujianto, MM., Apt. (Development Director)
4. Drs. Jisman Siagian, Apt. (Supply Chain Director)
5. Drs. M. Wahyuli Syafari, Apt. (General director)


Lift with respect:


1. Honesti Basyir (President Director)
2. I.G.N. Suharta Wijaya (Finance Director)
3. Pujianto (Director of Business Development)
4. Verdi Budidarmo (Director of Production & Supply Chain)
5. Arief Pramuhanto (Director General & Human Capital)

Therefore, the Composition and Position of the Board of Commissioners and Board of Directors of the Company shall be as follows:

B
oard of Commissioners


1. Dr. Farid Wadjdi Husain, Sp.B., KBD. (President Commissioner / Independent)
2. Prof. DR. Dewi Fortuna Anwar, MA. (Commissioner)
3. Prof. DR. Wahono Sumaryono, Apt. (Independent Commissioner)
4. dr. Untung Suseno Sutarjo, M. Kes. (Commissioner)
5. Muh. Umar Fauzi, ST., MSM. (Commissioner)

Board of Directors


1. Honesti Basyir (President Director)
2. I.G.N. Suharta Wijaya (Finance Director)
3. Pujianto (Director of Business Development)
4. Verdi Budidarmo (Director of Production & Supply Chain)
5. Arief Pramuhanto (Director General & Human Capital)

Company Performance 2016


In 2016, the Company successfully booked total assets of Rp 4.61 trillion, an increase of 34.29% from 2015 of Rp 3.43 trillion. The significant asset growth is a reflection of the increase in current assets owned by the Company, up 38.36% from Rp 2.91 billion from Rp 2.10 billion in 2015. This is in line with the Company's strategy to accelerate the development of hulurization and health network The Company in order to support the growth of public health through the National Health Insurance program (JKN) and increase the value of the Company in the long term.


In addition, To optimize its assets as one of the non-core strategies, the Company undertook the construction of hotels and hospitals with the Built Operate Transfer (BOT) scheme of idle assets


As a manifestation of its role in developing public health, the Company is developing its rapid test tool business, the development of the Raw Materials Factory and Pharmaceutical Salt I Factory which has been inaugurated and started operation since last December.
Company Overview


PT Kimia Farma (Persero) Tbk is the largest pharmaceutical company in Indonesia with Healthcare Company from upstream to downstream including Factory, Research & Development, Marketing, International Business, Trading & Distribution, Pharmacy Service, Diagnostics, and Health clinic. The Company currently has subsidiaries to support its main business: PT Kimia Farma Apotek (retail healthcare), PT Kimia Farma Trading & Distribution (trading & distribution), PT Sinkona Indonesia Lestari (quinine and derivative manufacturing), PT Kimia Farma Sungwun Pharmacopia (manufacturing Raw material of medicine). As of December 2016, the Company has 900 Pharmacy networks, with 375 Health Clinics, 45 Clinical Laboratories and has 47 Trading & Distribution branches.


Kimia Farma is always committed to provide the best service and health solution for the society. If there are things to be consulted and asked, please contact contact center "Kimia Farma Care" in the number 1-500-255, from Monday - Sunday at 07.00 - 21.00 WIB (local pulse). In the contact center, the public can obtain various information needed, either direct drug consultation with Pharmacist, Chem Farm Pharmacy nearby location and other information.